Hoth Therapeutics Inc (HOTH)       0.415  0 (-1%)

0.415  0 (-1%)

US44148G1058 - Common Stock - After market: 0.4001 -0.01 (-3.59%)

News Image
5 days ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Granted 180 Day Extension by Nasdaq to Regain Compliance with Bid Price Rule

/PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("Hoth" or the "Company") today announced that the Company received confirmation from the Listing...

News Image
13 days ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Announces HREC Approval in Australia for the Next Phase of its Trial of BioLexa for Patients with Atopic Dermatitis

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced it has received approval by the Bellberry...

News Image
19 days ago - BusinessInsider

Hoth Announces Adjournment of Annual Meeting of Shareholders Until June 23, 2022

NEW YORK, June 15, 2022 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that ...

News Image
19 days ago - Hoth Therapeutics, Inc.

Hoth Announces Adjournment of Annual Meeting of Shareholders Until June 23, 2022

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that its Annual Meeting of Shareholders...

News Image
25 days ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Announces Extension of Washington University Alzheimer's Mouse Model Study with Alzheimer's Therapeutic HT-ALZ

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that it has entered into an extension of...

News Image
2 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Announces Preliminary Efficacy Findings From Phase 1b Clinical Trial with Mild to Moderate Atopic Dermatitis Patient Cohort

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the preliminary findings from Hoth's...

News Image
3 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Announces New Pipeline Asset, HT-TBI for Stroke and Traumatic Brain Injury

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the company is adding a new asset to its...

News Image
3 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc. Announces Closing of $7.0 Million Underwritten Public Offering Priced At-The-Market

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the closing of its previously announced...

News Image
3 months ago - BusinessInsider

Hoth Therapeutics Announces Acceptance to Present HT-ALZ Proof-of-Concept Alzheimer's Disease Data at the 2022 Alzheimer's Association International Conference

Dr. Yuede will present the preclinical Alzheimer's disease mouse model data for exploring HT-ALZ for the treatment of Alzheimer's diseaseNEW YORK,...

News Image
3 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Announces Acceptance to Present HT-ALZ Proof-of-Concept Alzheimer's Disease Data at the 2022 Alzheimer's Association International Conference

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced acceptance to present the preclinical...

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning! It's time for another dive into the market this morning with a look at the biggest pre-market stock movers for Tuesday!

News Image
3 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc. Announces Pricing of $7.0 Million Underwritten Public Offering Priced At-The-Market

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the pricing of its underwritten public...

News Image
3 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced it has commenced an underwritten public...

News Image
3 months ago - InvestorPlace

Why Is SoFi (SOFI) Stock Down to New 52-Week Lows Today?

SoFi Technologies (SOFI) stock isn't doing so well on Monday after the stock dropped to a new 52-week low and we know why!

News Image
3 months ago - InvestorPlace

Is WBD Stock a Buy? 3 Analysts Weigh In on Warner Bros. Discovery.

Warner Bros. Discovery (WBD) stock is on the move today following the merger between Warner Bros. and Discovery last week.

News Image
3 months ago - InvestorPlace

Why Is Hoth Therapeutics (HOTH) Stock Skyrocketing 110% Today?

Hoth Therapeutics (HOTH) stock is rising higher on Monday after the biopharmaceutical company provided an update on HT-KIT.

News Image
3 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics mRNA Frame-Shifting Therapeutic, HT-KIT, Proves Effective Against Aggressive Cancer Cells

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced a development updates for its novel cancer...

News Image
3 months ago - BusinessInsider

Hoth Therapeutics Announces Pipeline Presentation at the 2022 BIO International Convention

Dr. Stefanie Johns, Chief Scientific Officer, will present updates on the Hoth Therapeutics Pipeline, including new proof-of-concept data for HT-A...

News Image
3 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Announces Pipeline Presentation at the 2022 BIO International Convention

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the company will be presenting at the BIO...

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning, trader! It's time for another round of the biggest pre-market stock movers before the opening bell on Thursday!

News Image
3 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Announces it Has Successfully Completed Manufacturing Feasibility of the HT-KIT Drug Substance

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced development updates for its cancer...

News Image
4 months ago - Hoth Therapeutics, Inc.

Hoth Therapeutics Announces Orphan Drug Designation Granted to Cancer Therapeutic HT-KIT to Treat Mastocytosis

NEW YORK, March 11, 2022 /PR Newswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the U.S. Food...

News Image
4 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Good morning, traders! We're starting the final day of the workweek with a look at the biggest pre-market stock movers for Friday!